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Establishment of 
Biomphalaria 
tenagophila Snails 
in Europe
To the Editor: Schistosomiasis, 
known since ancient times, is caused 
by blood ﬂ  ukes (Trematoda: Schisto-
somidae). It is a major communicable 
disease with public health and socio-
economic effects in the developing 
world (1). Among parasitic diseases, 
schistosomiasis ranks second only 
to malaria with regard to the number 
of persons infected and at risk. The 
life cycle of schistosomes is com-
plex, requiring speciﬁ  c  freshwater 
snails as intermediate hosts for lar-
vae development and multiplication. 
Among Schistosoma species that af-
fect humans, Schistosoma mansoni is 
the most likely to invade new areas 
mainly because of the adaptability 
and invasiveness of its intermediate 
host,  Biomphalaria snails. Natural 
populations of these snails are usu-
ally found in tropical standing water 
or freshwater in South America and 
Africa, but they also reach 30° lati-
tude in subtropical areas (1,2). Many 
species of these red-blooded planor-
bid snails (Gastropoda: Basommato-
phora) are able to survive a long time 
when removed from their freshwater 
habitat (1). Of the 34 Biomphalaria 
species, 4 (B. glabrata, B. pfeifferi, B. 
straminea, and B. tenagophila) have 
recently expanded their native ranges 
(3). They have been introduced to ar-
eas where other Biomphalaria species 
are endemic (e.g., Congo and Egypt) 
or to subtropical zones that have no 
frost period (Texas, Louisiana, Flor-
ida, Hong Kong) (3,4). None of the 
known invasions, whether peripheral 
range expansion or long distance dis-
persal, reached the temperate zone. 
Spreading of the blood-ﬂ  uke snails to 
schistosome-free areas may enable the 
parasite to colonize new habitats con-
currently, expanding the potential area 
of clinical schistosomiasis.
We collected these snails in spring 
2005, autumn 2006, and autumn 2007, 
near Răbăgani, Romania, Eastern Eu-
rope (46°45′1.3′′N, 22°12′44.8′′E) in 
a hypothermal spring. Water tempera-
ture was 25°C in the spring and 16°C–
25°C, gradually decreasing, along 
the brook course. In and beside an 
abandoned concrete pool next to the 
spring, we collected 100 shells and 34 
living specimens that macroscopically 
resembled  Biomphalaria spp. snails. 
All 16 dissected animals proved to 
be fully developed adults, according 
to the maturity of their genital organs 
(Figure). Using available identiﬁ  ca-
tion keys (5), we tentatively identiﬁ  ed 
these snails as B. tenagophila. Vouch-
er specimens have been deposited in 
the Hungarian Natural History Muse-
um (accession nos. HNHM96857 and 
HNHM95433).
DNA was extracted from the 
foot muscles of 3 specimens by using 
QIAamp DNA Mini Kit (QIAGEN, 
Hilden, Germany). For ampliﬁ  cation 
of the partial mitochondrial 16S ri-
bosomal RNA gene, we used a PCR 
with primers 16Sar and 16Sbr (6). 
Nucleotide sequences were deter-
mined in both directions. PCR prod-
ucts of ≈430 bp were detected from all 
3 samples. Automatic cycle sequenc-
ing of the randomly selected amplicon 
(GenBank accession no. EU069412) 
showed 99.74% similarity to B. tena-
gophila (AF449615, Brazil).
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Our morphologic, anatomic, and 
molecular data unambiguously prove 
the occurrence of B. tenagophila 
snails in Romania. B. tenagophila 
snails had been found earlier (in 2004) 
at this location but had presumably 
been misidentiﬁ  ed as dwarf specimens 
of a common European species, Plan-
orbarius corneus ( 7). Consequently, 
B. tenagophila snails have been not 
only introduced, but also established 
in Răbăgani, representing the furthest 
self-sustaining population of this spe-
cies from the equator.
B. tenagophila is a new species 
for the European fauna. It could repre-
sent a founder population of unknown 
origin for further spread into Europe, 
which might easily be accomplished 
by migrating birds or more likely by 
plants used in aquariums (3). Although 
no trematode larvae were detected in 
the observed specimens, clinical schis-
tosomiasis can be imported by immi-
grants or tourists into Europe, as has 
been reported in Romania and neigh-
boring Hungary (8,9). If eggs were 
released in feces of humans infected 
with the blood ﬂ  ukes, they could hatch 
in the environment and the larvae 
could develop to an infective stage 
in these snails. The observed local 
cultural and social factors involving 
natural water (washing clothes, bath-
ing) in Răbăgani where B. tenagophila 
have been found may also increase the 
chance of human infection.
We believe that B. tenagophila 
in Europe, together with the global 
climate change and a possible encoun-
ter of these snails with schistosomes, 
could pose a public health risk. Mea-
sures must be taken to prevent the 
spread of this species into European 
freshwater. Chemical control is not 
possible in Răbăgani because it is an 
area where other rare and endangered 
snail species are protected (7). There-
fore, the manual collection and remov-
al of all the B. tenagophila specimens 
in the area seems to be the only pos-
sibility for eradication, which might 
remain in effect for years. To avoid 
similar establishments, we suggest 
regular malacologic and parasitologic 
surveillance of at least the thermal and 
hypothermal water bodies for these 
tropical invaders around European 
settlements.
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Figure. A) Shell morphology of Biomphalaria tenagophila snail from Romania. Diameter of the shell was 10–14 mm. The sinistrally coiled, 
ﬂ  at shells are yellow-brown, discoidal, deeply and symmetrically biconcave, and consist of 5 or 6 slowly increasing whorls. The last whorl 
is rounded; the intermediate whorls are slightly angled on the left side. The aperture is circular or slightly ovate and angled toward the left 
side of the shell (i.e., toward the upper surface on the bottom right shell). Fine, parallel, rib-like transverse lines can be seen on the outer 
surface of the whorls. A series of photographs were prepared by focusing on different levels of the structure and these were combined by 
CombineZ5 (www.hadleyweb.pwp.blueyonder.co.uk), using “do combine” and “do average and ﬁ  lter” commands. Scale bar = 3 mm. B) 
Reproductive system of B. tenagophila snail from Romania; ag, albumin gland; bc, bursa copulatrix; hp, distal part of the hepatopancreas; 
ng, nidamental gland; od, oviduct; ot, ovotestis; pp, preputium; pr, prostate; ps, penis sheath; sd, spermiduct; sv, seminal vesicles; vd, vas 
deferens; vp, vaginal pouch. B. tenagophila–speciﬁ  c characteristics (5): >200 diverticulae of the ovotestis; 7–11 main lobes of the prostate; 
and presence of vaginal pouch. Scale bar = 1 mm.
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Rickettsia 
aeschlimannii 
Infection, Algeria
To the Editor: Only 2 cases of 
Rickettsia aeschlimannii infection 
have been reported. We report 2 addi-
tional cases documented in Algeria by 
immunoﬂ  uorescence (IF) assays and 
conﬁ  rmed by Western blot (WB) as-
says and cross-adsorption studies. 
Tick-borne rickettsioses are now 
recognized as emerging or reemerging 
human infections worldwide. These 
zoonoses, caused by intracellular bac-
teria within spotted fever group (SFG) 
Rickettsia spp., share characteristic 
clinical features including fever, rash, 
and sometimes inoculation eschar at 
the bite site (1). In North Africa, cases 
of rickettsioses are rarely documented 
(2). In Algeria, only Mediterranean 
spotted fever caused by R. conorii has 
been described (3).
From 2000 through 2006 in Al-
geria, all patients with suspected rick-
ettsioses seen at the infectious diseases 
units of Constantine and Batna hos-
pitals were included in a prospective 
study; clinical and epidemiologic data 
and acute-and convalescent-phase se-
rum samples obtained 2–4 weeks later 
were collected. Serum samples were 
sent to Marseille, France, where they 
were analyzed by an IF assay, using 
9 SFG rickettsial antigens (R. conorii 
conorii, R. conorii israelensis, R. afri-
cae, R. sibirica mongolitimonae, R. ae-
schlimannii, R. massiliae, R. helvetica, 
R. slovaca, and R. felis) and a typhus 
group antigen (R. typhi) (3). The IF as-
say result was considered positive 1) 
if immunoglobulin (Ig) G titers were 
>128 and/or IgM titers were >64 for R. 
conorii and 2) if IgG titers were >64 
and/or IgM titers were >32 for other 
rickettsial antigens (3). When cross-re-
actions between several antigens were 
noted, rickettsial antigen was consid-
ered to represent the infectious agent 
if titers of IgG and/or IgM antibody 
against this antigen were at least 2-fold 
higher than titers of IgG and/or IgM 
antibody against other rickettsial anti-
gens (3,4). When the difference in ti-
ters among several antigens was lower 
than 2-fold, WB assays and cross-ad-
sorption studies were performed (4,5). 
A total of 135 patients were included in 
the study. We describe 2 cases of R. ae-
schlimannii infection. Cases caused by 
other SFG rickettsiae will be reported 
elsewhere.
An 80-year-old man who report-
ed contact with dogs parasitized by 
ticks had a 7-day history of high fe-
ver, headache, myalgia, and vomiting. 
On physical examination, a general-
ized maculopapular rash, 2 eschars 
(right shoulder and knee), and bilat-
eral hemorrhagic signs on the retina 
were noticed. Elevated levels of liver 
enzymes (aspartate aminotransferase 
187 U/L, alanine aminotransferase 
108 U/L), hyponatremia (sodium 120 
mmol/L), and hypokalemia (potas-
sium 2.9 mmol/L) were found. IF as-
say showed raised levels of IgG/IgM 
against  R. aeschlimannii (512/64) 
and R. conorii (128/0). 
The second patient, a 36-year-
old man, reported a 15-day history 
of fever with headache and failure of 
amoxicillin and cotrimoxazole treat-
ments. Oral aphtous, a maculopapu-
lar rash, and purpuric lesions on the 
arms were noticed. IF assay showed 
raised levels of IgG/IgM at the same 
titer (2,048/32) against R. conorii, R. 
aeschlimannii, and R. massiliae. WB 
assays and cross-adsorption studies 
conﬁ  rmed that antibodies were direct-
ed against R. aeschlimannii (Figure). 
Both patients recovered after doxycy-
cline treatment (1). 
R. aeschlimannii was ﬁ  rst charac-
terized as a new SFG rickettsia after 
its isolation from Hyalomma margin-
atum marginatum ticks in Morocco in 
1997 (6). Thereafter, R. aeschlimannii 
has been detected in this tick species 
in southern Europe and North Africa 
(7), as well as in H. m. ruﬁ  pes in sub-
Saharan Africa (1). Preliminary data 
have suggested that these Hyalomma 
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